|
Report: Nearly 1 in 3 Israelis Refuse COVID-19 Treatment Pill.
|
3
|
Resverlogix Corp.
|
Jan 13, 2022 12:59PM
|
|
Re: COVID-19 "competition" to keep an eye on.
|
3
|
Resverlogix Corp.
|
Feb 09, 2021 03:33PM
|
|
Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study
|
3
|
Resverlogix Corp.
|
Sep 08, 2021 07:24PM
|
|
Potential new use for apabetalone?
|
3
|
Resverlogix Corp.
|
Feb 27, 2022 01:43AM
|
|
September 24th.
|
3
|
Resverlogix Corp.
|
Sep 24, 2021 03:05AM
|
|
Re: So, the mood this week was.
|
3
|
Resverlogix Corp.
|
Aug 20, 2021 08:31PM
|
|
Re: Zacks
|
3
|
Zenith Epigenetics
|
May 07, 2020 01:28PM
|
|
Re: Dec 22
|
3
|
Resverlogix Corp.
|
Nov 10, 2020 01:00PM
|
|
Re: Round one
|
3
|
Resverlogix Corp.
|
Jan 27, 2022 11:14PM
|
|
EVERSANA: Partnering & Licensing.
|
3
|
Resverlogix Corp.
|
Jul 15, 2021 12:18PM
|
|
Bayer and the CKD space we wanted to dominate in.
|
3
|
Resverlogix Corp.
|
Oct 25, 2020 02:17AM
|
|
So, we have a consultant.
|
3
|
Resverlogix Corp.
|
Sep 29, 2021 12:04PM
|
|
Re: "So if you get fantastic results in a Brazilian COVID-19 clinical trial, be prepared..." is my read.
|
3
|
Resverlogix Corp.
|
Aug 02, 2021 03:09PM
|
|
CTO is here to help move forward COVID-19 studies as quickly as possible.
|
3
|
Resverlogix Corp.
|
Jul 15, 2021 12:41PM
|
|
Re: Merck’s pill
|
3
|
Resverlogix Corp.
|
Oct 07, 2021 02:48PM
|
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 11, 2021 03:21PM
|
|
Re: Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2).
|
3
|
Resverlogix Corp.
|
Aug 24, 2021 03:00PM
|
|
SO078 APABETALONE, A BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES ALKALINE PHOSPHATASE IN CVD PATIENTS....
|
3
|
Resverlogix Corp.
|
May 02, 2020 11:35PM
|
|
Just brutal!
|
3
|
Resverlogix Corp.
|
Mar 14, 2022 07:16PM
|
|
Re: buy on rumour sell on news?
|
3
|
Resverlogix Corp.
|
Mar 01, 2021 07:56PM
|
